FDA's Foreign Drug Manufacturing Inspection Process

The Senate Finance Committee held a hearing with drug manufacturers and Food and Drug Administration officials on the agency’s foreign drug… read more

The Senate Finance Committee held a hearing with drug manufacturers and Food and Drug Administration officials on the agency’s foreign drug manufacturing inspection process. The witnesses discussed vulnerabilities the supply chain faces with foreign markets, the important of surprise inspections on foreign manufacturers, and the how the COVID-19 pandemic had highlighted the need to manufacture more critical pharmaceuticals in the United States. They also addressed how the needs associated with the pandemic have provided further stress and challenges to the current U.S. drug supply. close

Report Video Issue

People in this video

  • Mark Abdoo Associate Commissioner U.S. Food and Drug Administration->Global Policy amd Strategy
  • Sherrod Brown U.S. Senator (Class 1) [D] Ohio
More People

Hosting Organization

More information about

FDA's Foreign Drug Manufacturing Inspection Process

541 Views
Program ID:
472613-1
Category:
Senate Committee
Format:
Senate Committee
Location:
SD-106, Dirksen Senate Office Building, Washington, District of Columbia, United States
First Aired:
Jun 02, 2020 | 2:32pm EDT | C-SPAN 1
Last Aired:
Jun 02, 2020 | 10:27pm EDT | C-SPAN 2

Airing Details

  • Jun 02, 2020 | 2:32pm EDT | C-SPAN 1
  • Jun 02, 2020 | 10:27pm EDT | C-SPAN 2
Purchase a Download

FDA's Foreign Drug Manufacturing Inspection Process

  • MP4 video - Standard
    Price:
    $9.99 or Free with MyC‑SPAN
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video